A randomized study comparing interferon (IFNα) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML)-Reference-Cited by-同舟云学术

A randomized study comparing interferon (IFNα) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML)

Published:2003-05 Issue:5 Volume:27 Page:405-411
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Kühr T.,Burgstaller S.,Apfelbeck U.,Linkesch W.,Seewann H.,Fridrik M.,Michlmayr G.,Krieger O.,Lutz D.,Lin W.,Pont J.,Köck L.,Abbrederis K.,Baldinger C.,Buder R.,Geissler D.,Hausmaninger H.,Lang A.,Zabernigg A.,Duba C.,Hilbe W.,Eisterer W.,Fiegl M.,Greil R.,Gastl G.,Thaler J.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference16 articles.

1. The Italian Cooperative Study Group on Chronic Myeloid Leukemia. Interferon α-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. N Engl J Med 1994;330:820–5.

2. UK Medical Research Council randomised, multicentre trial of interferon α n1 for chronic myeloid leukemia: improved survival irrespective of cytogenetic response;Allan;Lancet,1995

3. Ohnishi K, Ohno R, Tomonaga M, Kamada N, Onozawa K, Kuramoto A, Dohy H, Mizoguchi H, Miyawaki S, Tsubaki K, Miura Y, Omine M, Kobayashi T, Naoe T, Ohshima T, Hirashima K, Ohtake S, Takahashi I, Morishima Y, Naito K, Asou N, Tanimoto M, Sakuma A, Yamada K, and the Kouseisho Leukemia Study Group. A randomized trial comparing interferon with busulfan for newly diagnosed chronic myelogenous leukemia in chronic phase. Blood 1995;86:906–16.

4. Hehlmann R, Heimpel H, Hasford J, Kolb HJ, Pralle H, Hossfeld KK, Queißer W, Löffler H, Hochhaus A, Heinze B, Georgii A, Bartram CR, Greißhammer M, Bergmann L, Essers U, Falge C, Queißer U, Meyer P, Schmitz N, Eimermacher H, Walther F, Fett W, Kleeberg UR, Käbisch A, Nerl C, Zimmermann R, Meuret G, Techelle A, Kanz L, Tigges FJ, Schmid L, Brockhaus W, Tobler A, Reiter A, Perker M, Emmrich B, Verpoort K, Zankovich R, Wussow P, Prümmer O, Thiele J, Buhr T, Carbonell F, Ansari H, and the German CML Study Group. Randomized comparison of interferon α with Busulfan and Hydroxyurea in chronic myelogenous leukemia. Blood 1994;84:4064–77.

5. Chronic Myeloid Leukemia Trialists’ Collaborative Group. Interferon α versus chemotherapy for chronic myeloid leukemia: a meta-analysis of seven randomized trials. J Natl Cancer Inst 1997;89:1616–20.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of Hydroxyurea-Induced Cellular Senescence: An Oxidative Stress Connection?;Oxidative Medicine and Cellular Longevity;2021-10-18

2. Hydroxyurea‐induced senescent peripheral blood mesenchymal stromal cells inhibit bystander cell proliferation of JAK2V617F‐positive human erythroleukemia cells;The FEBS Journal;2019-05-23

3. Organic Nanoparticles as Drug Delivery Systems and Their Potential Role in the Treatment of Chronic Myeloid Leukemia;Technology in Cancer Research & Treatment;2019-01-01

4. Common Chemical Inductors of Replication Stress: Focus on Cell‐Based Studies;Biomolecules;2017-02-21

5. Automated Synthesis and Visualization of a Chemotherapy Treatment Regimen Network;STUD HEALTH TECHNOL;2013